Diamyd Medical (Germany) Market Value
| DMN Stock | EUR 0.95 0.04 4.04% |
| Symbol | Diamyd |
Diamyd Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Diamyd Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Diamyd Medical.
| 12/04/2022 |
| 11/23/2024 |
If you would invest 0.00 in Diamyd Medical on December 4, 2022 and sell it all today you would earn a total of 0.00 from holding Diamyd Medical AB or generate 0.0% return on investment in Diamyd Medical over 720 days. Diamyd Medical is related to or competes with ASPEN TECHINC, Sunny Optical, CapitaLand Investment, Virtus Investment, Clean Energy, and NetSol Technologies. Diamyd Medical AB , a diabetes company, engages in the development of combination therapies for the treatment of autoimm... More
Diamyd Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Diamyd Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Diamyd Medical AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 16.44 | |||
| Value At Risk | (4.32) | |||
| Potential Upside | 5.88 |
Diamyd Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Diamyd Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Diamyd Medical's standard deviation. In reality, there are many statistical measures that can use Diamyd Medical historical prices to predict the future Diamyd Medical's volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (0.52) |
Diamyd Medical AB Backtested Returns
Diamyd Medical AB secures Sharpe Ratio (or Efficiency) of -0.16, which denotes the company had a -0.16% return per unit of standard deviation over the last 3 months. Diamyd Medical AB exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Diamyd Medical's Standard Deviation of 3.59, coefficient of variation of (700.46), and Mean Deviation of 2.9 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.01, which means a somewhat significant risk relative to the market. Diamyd Medical returns are very sensitive to returns on the market. As the market goes up or down, Diamyd Medical is expected to follow. At this point, Diamyd Medical AB has a negative expected return of -0.56%. Please make sure to confirm Diamyd Medical's mean deviation, jensen alpha, potential upside, as well as the relationship between the standard deviation and treynor ratio , to decide if Diamyd Medical AB performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.61 |
Very good reverse predictability
Diamyd Medical AB has very good reverse predictability. Overlapping area represents the amount of predictability between Diamyd Medical time series from 4th of December 2022 to 29th of November 2023 and 29th of November 2023 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Diamyd Medical AB price movement. The serial correlation of -0.61 indicates that roughly 61.0% of current Diamyd Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.61 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Diamyd Medical AB lagged returns against current returns
Autocorrelation, which is Diamyd Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Diamyd Medical's stock expected returns. We can calculate the autocorrelation of Diamyd Medical returns to help us make a trade decision. For example, suppose you find that Diamyd Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Diamyd Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Diamyd Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Diamyd Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Diamyd Medical stock over time.
Current vs Lagged Prices |
| Timeline |
Diamyd Medical Lagged Returns
When evaluating Diamyd Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Diamyd Medical stock have on its future price. Diamyd Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Diamyd Medical autocorrelation shows the relationship between Diamyd Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Diamyd Medical AB.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Diamyd Stock
Diamyd Medical financial ratios help investors to determine whether Diamyd Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diamyd with respect to the benefits of owning Diamyd Medical security.